Skip to main content

Pharmacovigilance: When to Report Adverse Reactions to Contrast Media

  • Chapter
Contrast Media

Part of the book series: Medical Radiology ((Med Radiol Diagn Imaging))

  • 2895 Accesses

Abstract

The main objective of pharmacovigilance is the early detection of new adverse drug reactions. Health care professionals play a key role in safety surveillance, as they are frontline observers if serious and unexpected adverse effects occur. They are obliged to report their observations and suspicions to the regulatory authorities, thereby enabling the authorities to react in an appropriate and timely manner.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    Definitions: Adverse reaction. A response to a medicinal product which is noxious and unintended, Unexpected adverse reaction. An adverse reaction, the nature, severity, or outcome of which is not consistent with the summary of product characteristics.

References

  • Dukes G (1985) The effects of drug regulation. A survey based on European studies of drug regulation. MTP Press Limited, Lancaster

    Book  Google Scholar 

  • Finney DJ (1965) The design and logic of a monitor of drug use. J Chronic Dis 18:77–98

    Article  CAS  PubMed  Google Scholar 

  • Grobner T (2006) Gadolinium—a specific trigger for the development of nephrogenic fibrosing dermatopathy and nephrogenic systemic fibrosis? Nephrol Dial Transpl 21:1104–1108

    Article  CAS  Google Scholar 

  • Lenz W (1966) Malformations caused by drugs in pregnancy. Am J Dis Child 112:99–106

    CAS  PubMed  Google Scholar 

  • Regulation (EU) no. 1235/2010 amending Regulation (EC) 726/2004 and Directive 2010/84/EU amending Directive 2001/83/EC

    Google Scholar 

  • Stenver DI (2008) Pharmacovigilance: what to do if you see an adverse reaction and the consequences. Eur J Radiol 66:184–186

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Doris I. Stenver .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Stenver, D.I. (2014). Pharmacovigilance: When to Report Adverse Reactions to Contrast Media . In: Thomsen, H., Webb, J. (eds) Contrast Media. Medical Radiology(). Springer, Berlin, Heidelberg. https://doi.org/10.1007/174_2013_868

Download citation

  • DOI: https://doi.org/10.1007/174_2013_868

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-36723-6

  • Online ISBN: 978-3-642-36724-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics